Ophthalmic devices are medical devices used for diagnosing, treating, and preventing eye diseases. These devices are used to measure visual acuity, detect retinal diseases, diagnose glaucoma, and treat eye diseases such as cataracts and macular degeneration.
Global ophthalmic devices market is forecast to reach USD 69.2 billion by 2031 from 44.3 billion in 2022, with growth at CAGR of 6.9% during the forecast period 2023-2031.
North America dominated the overall ophthalmic devices market in 2018 due to its large patient population base and high awareness levels regarding new technologies in treating eye disorders such as glaucoma or cataract surgery (lens replacement surgery). Asia Pacific countries such as India have shown significant growth over the past few years due to their large population base coupled with rapid urbanization trends which have led to an increase in cases related to diabetes mellitus type 2 (DM2) resulting in diabetic retinopathy (DR).
The
ophthalmic devices market
is still in its nascent stage and has several challenges to overcome before it can reach its true potential. One major challenge this market faces is data security and privacy concerns. Data security refers to how well protected your personal information is from unauthorized access or modification while privacy refers to how much control you have over who sees what information about you when they see it and where they can get it from.
When people think about data privacy, they usually think about their social media accounts being hacked or someone stealing their credit card details online but there are other ways in which our private information can be compromised without us even realizing it!
The global ophthalmic devices market is segmented into product type and end user. The product type segment includes diagnostic devices, vision care products and therapeutic devices. The end user segment includes hospitals & medical clinics; pharmacies & retail outlets; home healthcare providers; and others.
The key players in this market include Abbott Laboratories Inc., Bausch + Lomb Incorporated, Carl Zeiss Meditec AG & Co., Novartis AG (Alcon), Johnson & Johnson Vision Care Inc., Koninklijke Philips Nv/S A (Philips), Medtronic Plc (Medtronic), Merck KGaA(Merck)and Pfizer In The global ophthalmic devices market is segmented into product type and end user. The product type segment includes diagnostic devices, vision care products and therapeutic devices. The end user segment includes hospitals & medical clinics; pharmacies & retail outlets; home healthcare providers; and others.
Original source
Ophthalmic Devices Market Size, Share, Regional Analysis, Key Players, Revenue and Forecast 2023-2031
created with
Website Builder Software .